4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001613377-19-000004
Chief Science/Medical Officer acquired 85,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| STRAYER DAVID R Chief Science/Medical Officer | 2019-03-25 | Conversion | +50,000 | 94,304 | D: show line 1 in the form | ||
| STRAYER DAVID R Chief Science/Medical Officer | 2019-05-08 | Conversion | +35,000 | 129,304 | D: show line 2 in the form |
Loading xslF345X03/primary_doc.xml…